The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
|
| FORM C |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 | OMB APPROVAL |
| OMB Number: ####-#### Estimated average burden hours per response: ##.# |
| Name of Issuer: | Nano Mobile Healthcare, Inc. |
Legal Status of Issuer: | |
| Form: | Corporation |
| Jurisdiction of Incorporation/Organization: |
NEVADA
|
| Date of Incorporation/Organization: | 01-09-2015 |
Physical Address of Issuer: | |
| Address 1: | ONE BOSTON PLACE, |
| Address 2: | SUITE 2600 |
| City: | BOSTON |
| State/Country: |
MASSACHUSETTS
|
| Mailing Zip/Postal Code: | 62108 |
| Website of Issuer: | www.vnthotc.com |
| Is there a Co-issuer? | ☐ Yes ☒ No |
Intermediary through which the Offering will be Conducted: | |
| CIK: | 0001667145 |
| Company Name: | truCrowd, Inc |
| Commission File Number: | 007-00015 |
| CRD Number: | 283063 |
| Amount of compensation to be paid to the intermediary, whether as a dollar amount or a percentage of the offering amount, or a good faith estimate if the exact amount is not available at the time of the filing, for conducting the offering, including the amount of referral and any other fees associated with the offering: | The intermediary will get paid a success fee of 8% |
| Any other financial interest in the issuer held by the intermediary, or any arrangement for the intermediary to acquire such an interest: | No |
| Type of Security Offered: | Other |
| Specify: | SAFE Note |
| Target Number of Securities to be Offered: | 10000 |
| Price: | 1.00000 |
| Price (or Method for Determining Price): | Arbitrarily |
| Target Offering Amount: | 10000.00 |
| Maximum Offering Amount (if different from Target Offering Amount): | 100000.00 |
| Oversubscriptions Accepted: | ☒ Yes ☐ No |
| If yes, disclose how oversubscriptions will be allocated: | Other |
| Provide a description: | At the issuer's discretion |
| Deadline to reach the Target Offering Amount: | 06-30-2022 |
| NOTE: If the sum of the investment commitments does not equal or exceed the target offering amount at the offering deadline, no securities will be sold in the offering, investment commitments will be cancelled and committed funds will be returned. | |
| Current Number of Employees: | 0.00 |
| Total Assets Most Recent Fiscal Year-end: | 0.00 |
| Total Assets Prior Fiscal Year-end: | 0.00 |
| Cash and Cash Equivalents Most Recent Fiscal Year-end: | 0.00 |
| Cash and Cash Equivalents Prior Fiscal Year-end: | 0.00 |
| Accounts Receivable Most Recent Fiscal Year-end: | 0.00 |
| Accounts Receivable Prior Fiscal Year-end: | 0.00 |
| Short-term Debt Most Recent Fiscal Year-end: | 0.00 |
| Short-term Debt Prior Fiscal Year-end: | 0.00 |
| Long-term Debt Most Recent Fiscal Year-end: | 0.00 |
| Long-term Debt Prior Fiscal Year-end: | 0.00 |
| Revenue/Sales Most Recent Fiscal Year-end: | 0.00 |
| Revenue/Sales Prior Fiscal Year-end: | 0.00 |
| Cost of Goods Sold Most Recent Fiscal Year-end: | 0.00 |
| Cost of Goods Sold Prior Fiscal Year-end: | 0.00 |
| Taxes Paid Most Recent Fiscal Year-end: | 0.00 |
| Taxes Paid Prior Fiscal Year-end: | 0.00 |
| Net Income Most Recent Fiscal Year-end: | 0.00 |
| Net Income Prior Fiscal Year-end: | 0.00 |
| Using the list below, select the jurisdictions in which the issuer intends to offer the securities: |
|
Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), the issuer certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form C and has duly caused this Form to be signed on its behalf by the duly authorized undersigned. |
| Issuer | Signature | Title |
|---|---|---|
| #Nano Mobile Healthcare, Inc. | Frank Igwealor | CEO |
Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated. |
| Signature | Title | Date |
|---|---|---|
| #Frank Igwealor | CEO | 09-27-2021 |